Exosomal miRNAs as potential biomarkers for acute myocardial infarction

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Medicine

Background:

• MicroRNAs (miRNAs) are recognized biomarkers for acute myocardial infarction (AMI).
• The role of exosomal miRNAs in the transition from stable coronary artery disease (SCAD) to AMI remains under-explored.
• Understanding these mechanisms is crucial for early diagnosis and intervention.

Purpose of the Study:

• To investigate the diagnostic value of exosomal miRNAs in differentiating SCAD from AMI.
• To explore the potential role of exosomal miRNAs in the pathophysiology of AMI progression.
• To identify specific exosomal miRNAs as predictive biomarkers for early-stage AMI.

Main Methods:

• Serum exosomes were isolated using ultracentrifugation and characterized by electron microscopy, western blotting, and nanoparticle tracking analysis.
• Differential expression of miRNAs between SCAD and AMI patients was screened using microarray analysis.
• Target gene prediction and pathway analysis were performed using bioinformatics tools.
• Quantitative real-time PCR validated the expression of candidate miRNAs in a larger cohort.

Main Results:

• Thirteen miRNAs were significantly downregulated in AMI exosome samples compared to SCAD samples.
• Target genes of these miRNAs are primarily involved in cardiac rehabilitation and remodeling pathways.
• Exosomal miR-1915-3p, miR-4,507, and miR-3,656 showed significantly lower expression in AMI patients.
• Receiver-operating-characteristic curve analysis indicated good predictive accuracy for these miRNAs (AUCs ranging from 0.684 to 0.772).

Conclusions:

• Serum exosomal miRNAs, particularly miR-1915-3p, miR-4,507, and miR-3,656, may serve as valuable early diagnostic biomarkers for AMI.
• These miRNAs potentially play a significant role in the pathophysiology of AMI.
• Further research into exosomal miRNAs could lead to improved diagnostic strategies for cardiovascular diseases.